Tamburrini Riccardo, Chaimov Deborah, Asthana Amish, Gazia Carlo, Enck Kevin, Muir Sean M, Aziz Justine Mariam, Lablanche Sandrine, Tubbs Emily, Tomei Alice A, Van Dyke Mark, Soker Shay, Opara Emmanuel C, Orlando Giuseppe
Department of Surgery, Wake Forest Baptist Medical Center; Department of General Surgery, PhD Program in Experimental Medicine, University of Pavia; Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine.
Department of Surgery, Wake Forest Baptist Medical Center; Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine.
J Vis Exp. 2020 Sep 4(163). doi: 10.3791/61663.
Islet transplantation (ITx) has the potential to become the standard of care in beta cell replacement medicine but its results remain inferior to those obtained with whole pancreas transplantation. The protocols currently used for human islet isolation are under scrutiny because they are based on the enzymatic digestion of the organ, whereby the pancreas is demolished, its connections to the body are lost and islets are irreversibly damaged. Islet damage is characterized by critical factors such as the destruction of the extracellular matrix (ECM), which represents the 3D framework of the islet niche and whose loss is incompatible with islet euphysiology. Researchers are proposing the use of ECM-based scaffolds derived from the mammalian pancreas to address this problem and ultimately improve islet viability, function, and lifespan. Currently available methods to obtain such scaffolds are harsh because they are largely detergent based. Thus, we propose a new, detergent-free method that creates less ECM damage and can preserve critical components of pancreatic ECM. The results show that the newly developed decellularization protocol allowed the achievement of complete DNA clearance while the ECM components were retained. The ECM obtained was tested for cytotoxicity and encapsulated with human pancreatic islets which showed a positive cellular behavior with insulin secretion when stimulated with glucose challenge. Collectively, we propose a new method for the decellularization of the human pancreas without the use of conventional ionic and non-ionic chemical detergents. This protocol and the ECM obtained with it could be of use for both in vitro and in vivo applications.
胰岛移植(ITx)有潜力成为β细胞替代医学的标准治疗方法,但其结果仍逊于全胰腺移植。目前用于人类胰岛分离的方案正受到审视,因为它们基于器官的酶消化,在此过程中胰腺被破坏,其与身体的连接丧失,胰岛也受到不可逆的损伤。胰岛损伤的特征在于关键因素,如细胞外基质(ECM)的破坏,细胞外基质代表胰岛微环境的三维框架,其丧失与胰岛正常生理功能不相容。研究人员提议使用源自哺乳动物胰腺的基于细胞外基质的支架来解决这一问题,并最终提高胰岛的活力、功能和寿命。目前获取此类支架的可用方法很苛刻,因为它们主要基于去污剂。因此,我们提出一种新的无去污剂方法,该方法造成的细胞外基质损伤较小,并且能够保留胰腺细胞外基质的关键成分。结果表明,新开发的去细胞化方案能够实现完全的DNA清除,同时保留细胞外基质成分。对所获得的细胞外基质进行细胞毒性测试,并将其与人胰岛封装在一起,当受到葡萄糖刺激时,这些胰岛表现出积极的细胞行为并分泌胰岛素。总体而言,我们提出了一种不使用传统离子和非离子化学去污剂的人胰腺去细胞化新方法。该方案及其所获得的细胞外基质可用于体外和体内应用。